Innoblative Designs Inc. is a medical device company committed to developing advanced-energy surgical solutions. The company is bringing to market the SIRA™ RFA Electrosurgical Device, a next-generation radiofrequency ablation (RFA) applicator designed specifically for intraoperative coagulation and ablation of soft tissue.
Prior to that Kelly Londy was CEO at Lumicell, Inc. a technology company in the field of image-guided cancer surgery. During her years at Lumicell, Inc. she oversaw a successful Series-C financing round and the implementation of a development strategy to expand its pipeline across seven solid tumour cancers.
Kelly’s extensive experience also includes six years at Accuray where she held executive roles as Chief Operating Officer and Chief Commercial Officer providing leadership across all customer facing activities. During her career, she has also served as Vice President and General Manager of Molecular Imaging at GE Healthcare North America and held multiple leadership roles at Philips Healthcare North America.
Kelly was one of the early voices in the market calling for patients to have more information, insight and greater control over their healthcare decisions, as well as being an advocate for making great technology available to all patients, not just the economically advantaged.